CERo Therapeutics Holdings, Inc entered into a purchase agreement with Arena Business Solutions Global SPC II, Ltd, pursuant to the agreement the company has agreed to issue common stock for proceeds of $25 million on February 23, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | -2.84% | -8.67% | -87.55% |
Apr. 02 | CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 11 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-87.55% | 20.17M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- CERo Therapeutics Holdings, Inc. announced that it expects to receive $25 million in funding from Arena Business Solutions Global SPC II, Ltd.